Additionally, GP73 levels were considerably elevated in patients with significant necroinflammation, fibrosis, or cirrhosis [36,37,40,41,42], suggesting that GP73 could be used as a reliable surrogate marker for the detection of advanced fibrosis and cirrhosis but also for the monitoring of patients with liver diseases [16,37,40,43,44,45]. This evidence concerns the gene GOLM1 and Cirrhosis.